We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04610528
Brief Title: A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression (TOT-HER3)

First Submitted : October 27, 2020
First Submitted that Met QC Criteria : October 29, 2020
First Posted : October 30, 2020

Last Update Submitted that Met QC Criteria : April 1, 2022
Last Update Posted : April 4, 2022